Patent · US Active

Chimpanzee adenoviral vector-based filovirus vaccines

US11913013B2 · kind B2 · utility

0Cited by

3References

5Claims

0Family size

Assignee

SABIN VACCINE INSTITUTE · US

Inventors

Nancy Sullivan · Kensington, US
Gary J. Nabel · Cambridge, US
Clement Asiedu · Olney, US
Cheng Cheng · Bethesda, US
Alfredo Nicosia · Siena, IT
Riccardo Cortese · Roma, IT
Virginia Ammendola · Napoli, IT
Stefano Colloca · Roma, IT

Key dates

Filing date	Jul 30, 2021
Grant date	Feb 27, 2024
Priority date	—
Expiry date	Nov 19, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/14134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.